Related Experiment Video
Updated: Jan 16, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Hemodynamic Patterns in Septic Cardiomyopathy: Insights From Echocardiographic Parameters and Biomarker Analysis
Rabia Jaffar1,2, Ahmed Jamal Chaudhary3, Marium Nadeem Khan4
1Internal Medicine, Tunbridge Wells Hospital, Tunbridge Wells, GBR.
Abstract:
Introduction Septic cardiomyopathy (SCM) refers to an acute, reversible impairment of cardiac performance. This study aimed to evaluate hemodynamic patterns in SCM using echocardiographic parameters and cardiac biomarkers in critically ill patients. Materials and methods A 12-month prospective observational study was conducted at a single tertiary care center in Peshawar, Pakistan. Adult ICU patients with sepsis or septic shock underwent transthoracic echocardiography (TTE) within 48 hours of admission, with a repeat study on day 5 or earlier if clinically indicated. Left ventricular (LV) and right ventricular (RV) systolic and diastolic functions were assessed, including global longitudinal strain (GLS) and RV free-wall strain. High-sensitivity troponin I (hs-TnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were measured on days 1 and 3. Associations between cardiac dysfunction and in-hospital mortality were analyzed using multivariable logistic regression after adjusting for age, sex, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and vasopressor use. Results Among 122 patients, the prevalence of SCM, defined by LV GLS > -17%, was high, with concurrent RV dysfunction observed in a significant proportion. Elevated hs-TnI and NT-proBNP levels correlated with impaired GLS and adverse outcomes. After multivariable adjustment, GLS impairment and elevated NT-proBNP remained independently associated with in-hospital mortality. Conclusions In this South Asian cohort with sepsis or septic shock, combined strain-based echocardiography and biomarker profiling revealed distinct patterns of myocardial dysfunction associated with early mortality. While these findings highlight the prognostic utility of GLS and NT-proBNP, they should be interpreted as associations rather than causal effects. Larger multicenter studies with extended follow-up and incorporation of additional biomarkers and advanced imaging are needed to validate these observations and clarify underlying pathophysiological mechanisms.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

